Security key
918385204
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)
CUSIP: 918385204
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 3,948,649
- Total 13F shares
- 571,712
- Share change
- +20,296
- Total reported value
- $9,902,095
- Price per share
- $17.32
- Number of holders
- 20
- Value change
- +$353,201
- Number of buys
- 7
- Number of sells
- 7
Report period
Q1 2025
Institutions
20
Top holders
10
VTVT full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
vTv Therapeutics Inc. SEC filings
vTv Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 918385204
Recent filing periods:
Top shareholders of VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Samsara BioCapital, LLC |
13F
|
Company |
5.2%
|
206,784
|
$2,855,418 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
4.5%
|
178,200
|
$2,427,084 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.5%
|
97,314
|
$1,343,780 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
41,558
|
$566,020 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
11,634
|
$158,490 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
7,512
|
$103,733 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.12%
|
4,773
|
$65,910 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
1,803
|
$24,557 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
1,146
|
$15,824 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
383
|
$5,000 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
170
|
$2,347 | — | 31 Dec 2024 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
50
|
$690 | — | 31 Dec 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
38
|
$525 | — | 31 Dec 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
19
|
$268 | — | 31 Dec 2024 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
15
|
$210 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
9
|
$124 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
8
|
$110 | — | 31 Dec 2024 | |
| Ronald O Perelman |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
36,519,212
|
$30,482,586 | — | 20 Dec 2021 | |
| Samsara BioCapital GP, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,099,362
mixed-class rows
|
$14,038,836 | — | 05 Mar 2024 | |
| G42 Investments AI Holdings RSC Ltd. |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,386,274
|
— | — | 31 May 2022 | |
| Hh Sheikh Tahnoon bin Zayed S. Al-Nahyan |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
10,386,274
|
— | — | 31 May 2022 | |
| Deepa Prasad |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
2,498,635
|
$29,508,879 | — | 19 Oct 2021 | |
| Rich S. Nelson |
3/4/5
|
Acting Chief Executive Officer, Director |
—
class O/S missing
|
500,000
|
$5,905,000 | — | 03 Mar 2022 | |
| Chandresh Harjivan |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Hersh Kozlov |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Howard L. Weiner |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| John A. Fry |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Keith R. Harris |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
$1,203,000 | — | 19 Jun 2023 | |
| Steven L. Tuch |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
74,659
|
$881,723 | — | 27 Feb 2024 |
Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) as of Q1 2025
As of 31 Mar 2025,
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
571,712 shares.
The largest 10 holders included
SAMSARA BIOCAPITAL, LLC, FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Connective Capital Management, LLC, BlackRock, Inc., UBS Group AG, and MORGAN STANLEY.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
17
Q1 2025 holders
20
Holder diff
3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.